Why the study?
Purulent pericarditis carries high mortality and risk of constrictive pericarditis due to fibrinous loculations, but the choice, dosage, and administration method of intrapericardial fibrinolytic therapy remain under debate.
Does intrapericardial fibrinolytic therapy prevent constrictive pericarditis in patients with purulent pericarditis?
Does intrapericardial fibrinolytic therapy prevent constrictive pericarditis in patients with purulent pericarditis?
Intrapericardial administration of fibrinolytics in purulent pericarditis may safely dissolve fibrin and collagen, improving drainage and potentially preventing constrictive pericarditis.
No takes yet. Share an insight, caveat, or question.
Urgent drainage and antibiotics remain essential in PP; leaves open optimal strategies for fibrin loculations.
Dybowska et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: